Tomomi Manako

Monitoring the neutrophil‐to‐lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer

Ryuji Yasumatsu, Takahiro Wakasaki, Kazuki Hashimoto et al. · Head & Neck · 2019 · 58 citations

Individualized circulating tumor <scp>DNA</scp> monitoring in head and neck squamous cell carcinoma

Ryunosuke Kogo, Tomomi Manako, Takeshi Iwaya et al. · Cancer Medicine · 2022 · 36 citations · Full text

Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Takahiro Wakasaki, Ryuji Yasumatsu, Muneyuki Masuda et al. · Cancers · 2020 · 32 citations · Full text

Inflammation-based Prognostic Score as a Prognostic Biomarker in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab Therapy

Mioko Matsuo, Ryuji Yasumatsu, Muneyuki Masuda et al. · In Vivo · 2022 · 26 citations · Full text

Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study

Takahiro Wakasaki, Tomomi Manako, Ryuji Yasumatsu et al. · PLoS ONE · 2022 · 19 citations · Full text